Clinical Trials · NCT06807437

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Name: Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 3Lanreotide

Phase: Phase 3
Recruitment status: Recruiting
Sponsor: SWOG Cancer Research Network
Enrollment: 274
Start date: May 2025
Locations: 118 sites, United States
Primary endpoint: Incidence of postoperative pancreatic fistula (POPF)

View Lanreotide compound reference